{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:43:09Z","timestamp":1793475789180,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A1B03031483"],"award-info":[{"award-number":["2017R1D1A1B03031483"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of hepatocellular carcinoma (HCC) surveillance is being questioned in alcoholic cirrhosis because of the relative low HCC risk. This study aimed to assess the risk and predictors of HCC in Korean patients with alcoholic cirrhosis by using competing risk analysis. A total of 745 patients with alcoholic cirrhosis were recruited at a university-affiliated hospital in Korea and randomly assigned to either the derivation (n\u2009=\u2009507) and validation (n\u2009=\u2009238) cohort. Subdistribution hazards model of Fine and Gray was used with deaths and liver transplantation treated as competing risks. Death records were confirmed from Korean government databases. A nomogram was developed to calculate the Alcohol-associated Liver Cancer Estimation (ALICE) score. The cumulative incidence of HCC was 15.3 and 13.3% at 10\u00a0years for derivation and validation cohort, respectively. Age, alpha-fetoprotein level, and albumin level were identified as independent predictors of HCC and incorporated in the ALICE score, which discriminated low, intermediate, and high risk for HCC in alcoholic cirrhosis at the cut-off of 60 and 100. The risk of HCC can be stratified by using a combination of readily available clinical parameters (age, AFP level, and albumin level) in patients with alcoholic cirrhosis.<\/jats:p>","DOI":"10.1038\/s41598-022-05196-w","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T11:06:03Z","timestamp":1643799963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-0782","authenticated-orcid":false,"given":"Kyunghan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-8427","authenticated-orcid":false,"given":"Gwang Hyeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-2582","authenticated-orcid":false,"given":"Eun Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-7990","authenticated-orcid":false,"given":"Sook-Hyang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0934-3344","authenticated-orcid":false,"given":"Jin-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"5196_CR1","doi-asserted-by":"publisher","unstructured":"Collaborators, G. B. D. C. o. D. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736\u20131788. https:\/\/doi.org\/10.1016\/S0140-6736(18)32203-7 (2018).","DOI":"10.1016\/S0140-6736(18)32203-7"},{"issue":"1683\u20131691","key":"5196_CR2","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"C Global Burden of Disease Liver Canc","year":"1990","unstructured":"Global Burden of Disease Liver Cancer, C. et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the global Burden of Disease Study 2015. JAMA Oncol. 3(1683\u20131691), 2017. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3055 (1990).","journal-title":"JAMA Oncol."},{"key":"5196_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"Management of hepatocellular carcinoma","year":"2018","unstructured":"Management of hepatocellular carcinoma. European Association for the Study of the Liver. Electronic address, e. e. e. & European Association for the Study of the, L. EASL Clinical Practice Guidelines. J. Hepatol. 69, 182\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.019 (2018).","journal-title":"J. Hepatol."},{"key":"5196_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","volume":"70","author":"N Ganne-Carrie","year":"2019","unstructured":"Ganne-Carrie, N. & Nahon, P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 70, 284\u2013293. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.008 (2019).","journal-title":"J Hepatol"},{"key":"5196_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.01.005","author":"H Hagstrom","year":"2021","unstructured":"Hagstrom, H. et al. Risk of cancer in biopsy-proven alcohol-related liver disease: A population-based cohort study of 3410 persons. Clin. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2021.01.005 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"5196_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cld.2016.02.012","volume":"20","author":"K Joshi","year":"2016","unstructured":"Joshi, K., Kohli, A., Manch, R. & Gish, R. Alcoholic liver disease: High risk or low risk for developing hepatocellular carcinoma?. Clin. Liver Dis. 20, 563\u2013580. https:\/\/doi.org\/10.1016\/j.cld.2016.02.012 (2016).","journal-title":"Clin. Liver Dis."},{"key":"5196_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cgh.2012.09.007","volume":"11","author":"A Mancebo","year":"2013","unstructured":"Mancebo, A. et al. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin. Gastroenterol. Hepatol. 11, 95\u2013101. https:\/\/doi.org\/10.1016\/j.cgh.2012.09.007 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"5196_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7326\/0003-4819-156-12-201206190-00004","volume":"156","author":"P Jepsen","year":"2012","unstructured":"Jepsen, P., Ott, P., Andersen, P. K., S\u00f8rensen, H. T. & Vilstrup, H. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis. Ann. Intern. Med. 156, 841\u2013847 (2012).","journal-title":"Ann. Intern. Med."},{"key":"5196_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jhep.2018.07.022","volume":"69","author":"N Ganne-Carrie","year":"2018","unstructured":"Ganne-Carrie, N. et al. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis. J. Hepatol. 69, 1274\u20131283. https:\/\/doi.org\/10.1016\/j.jhep.2018.07.022 (2018).","journal-title":"J. Hepatol."},{"key":"5196_CR10","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jhep.2020.05.043","volume":"73","author":"P Jepsen","year":"2020","unstructured":"Jepsen, P. et al. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis. J. Hepatol. 73, 1030\u20131036. https:\/\/doi.org\/10.1016\/j.jhep.2020.05.043 (2020).","journal-title":"J. Hepatol."},{"key":"5196_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5060","volume":"349","author":"M Wolkewitz","year":"2014","unstructured":"Wolkewitz, M., Cooper, B. S., Bonten, M. J., Barnett, A. G. & Schumacher, M. Interpreting and comparing risks in the presence of competing events. BMJ 349, g5060. https:\/\/doi.org\/10.1136\/bmj.g5060 (2014).","journal-title":"BMJ"},{"key":"5196_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/atm.2018.07.38","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Overview of model validation for survival regression model with competing risks using melanoma study data. Ann. Transl. Med. 6, 325. https:\/\/doi.org\/10.21037\/atm.2018.07.38 (2018).","journal-title":"Ann. Transl. Med."},{"key":"5196_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4258\/hir.2012.18.2.145","volume":"18","author":"S Yoo","year":"2012","unstructured":"Yoo, S. et al. Seoul National University Bundang Hospital\u2019s electronic system for total care. Healthc. Inform. Res. 18, 145\u2013152. https:\/\/doi.org\/10.4258\/hir.2012.18.2.145 (2012).","journal-title":"Healthc. Inform. Res."},{"key":"5196_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168189","volume":"11","author":"JW Chung","year":"2016","unstructured":"Chung, J. W. et al. Optimizing surveillance performance of alpha-fetoprotein by selection of proper target population in chronic hepatitis B. PLoS ONE 11, e0168189. https:\/\/doi.org\/10.1371\/journal.pone.0168189 (2016).","journal-title":"PLoS ONE"},{"key":"5196_CR15","doi-asserted-by":"publisher","first-page":"S637","DOI":"10.21037\/jtd.2016.08.44","volume":"8","author":"S Yoo","year":"2016","unstructured":"Yoo, S., Hwang, H. & Jheon, S. Hospital information systems: experience at the fully digitized Seoul National University Bundang Hospital. J. Thorac. Dis. 8, S637-641. https:\/\/doi.org\/10.21037\/jtd.2016.08.44 (2016).","journal-title":"J. Thorac. Dis."},{"key":"5196_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero, J. A. et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68, 723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913 (2018).","journal-title":"Hepatology"},{"key":"5196_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach, J. K. et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67, 358\u2013380. https:\/\/doi.org\/10.1002\/hep.29086 (2018).","journal-title":"Hepatology"},{"key":"5196_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiol.2017170554","volume":"286","author":"A Tang","year":"2018","unstructured":"Tang, A. et al. Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: A systematic review. Radiology 286, 29\u201348. https:\/\/doi.org\/10.1148\/radiol.2017170554 (2018).","journal-title":"Radiology"},{"key":"5196_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144 (1999).","journal-title":"J. Am. Stat. Assoc."},{"key":"5196_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1536867X1701700110","volume":"17","author":"PC Lambert","year":"2017","unstructured":"Lambert, P. C. The estimation and modelling of cause-specific cumulative incidence functions using time-dependent weights. Stata J. 17, 181\u2013207 (2017).","journal-title":"Stata J."},{"key":"5196_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2019.05.008","volume":"71","author":"GN Ioannou","year":"2019","unstructured":"Ioannou, G. N., Green, P., Kerr, K. F. & Berry, K. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification. J. Hepatol. 71, 523\u2013533. https:\/\/doi.org\/10.1016\/j.jhep.2019.05.008 (2019).","journal-title":"J. Hepatol."},{"key":"5196_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.033","author":"SA Sharma","year":"2017","unstructured":"Sharma, S. A. et al. Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis. J. Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2017.07.033 (2017).","journal-title":"J. Hepatol."},{"key":"5196_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D'Amico","year":"2018","unstructured":"D\u2019Amico, G. et al. Clinical states of cirrhosis and competing risks. J. Hepatol. 68, 563\u2013576. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020 (2018).","journal-title":"J. Hepatol."},{"key":"5196_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27598","volume":"62","author":"P Jepsen","year":"2015","unstructured":"Jepsen, P., Vilstrup, H. & Andersen, P. K. The clinical course of cirrhosis: The importance of multistate models and competing risks analysis. Hepatology 62, 292\u2013302. https:\/\/doi.org\/10.1002\/hep.27598 (2015).","journal-title":"Hepatology"},{"key":"5196_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S. & Shah, V. H. ACG Clinical guideline: Alcoholic liver disease. Am. J. Gastroenterol. 113, 175\u2013194. https:\/\/doi.org\/10.1038\/ajg.2017.469 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"5196_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jhep.2020.12.029","volume":"74","author":"P Jepsen","year":"2021","unstructured":"Jepsen, P. & West, J. We need stronger evidence for (or against) hepatocellular carcinoma surveillance. J. Hepatol. 74, 1234\u20131239. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.029 (2021).","journal-title":"J. Hepatol."},{"key":"5196_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/jgh.14372","volume":"34","author":"HW Wang","year":"2019","unstructured":"Wang, H. W. et al. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy. J. Gastroenterol. Hepatol. 34, 442\u2013449. https:\/\/doi.org\/10.1111\/jgh.14372 (2019).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"5196_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3350\/cmh.2018.0108","volume":"25","author":"SK Na","year":"2019","unstructured":"Na, S. K. & Song, B. C. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C. Clin Mol Hepatol 25, 234\u2013244. https:\/\/doi.org\/10.3350\/cmh.2018.0108 (2019).","journal-title":"Clin Mol Hepatol"},{"key":"5196_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/liv.13555","volume":"38","author":"C Zhao","year":"2018","unstructured":"Zhao, C. et al. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue. Liver Int. 38, 503\u2013514. https:\/\/doi.org\/10.1111\/liv.13555 (2018).","journal-title":"Liver Int."},{"key":"5196_CR30","first-page":"1015","volume":"192","author":"S Yoo","year":"2013","unstructured":"Yoo, S., Kim, S., Lee, K. H., Baek, R. M. & Hwang, H. A study of user requests regarding the fully electronic health record system at Seoul National University Bundang Hospital. Stud. Health Technol. Inform. 192, 1015 (2013).","journal-title":"Stud. Health Technol. Inform."},{"key":"5196_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","volume":"66","author":"C Lackner","year":"2017","unstructured":"Lackner, C. et al. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J. Hepatol. 66, 610\u2013618. https:\/\/doi.org\/10.1016\/j.jhep.2016.11.011 (2017).","journal-title":"J. Hepatol."},{"key":"5196_CR32","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.cgh.2019.01.026","volume":"17","author":"ND Shah","year":"2019","unstructured":"Shah, N. D. et al. Alcohol-related liver disease is rarely detected at early stages compared with liver diseases of other etiologies worldwide. Clin. Gastroenterol. hepatol. 17, 2320-2329 e2312. https:\/\/doi.org\/10.1016\/j.cgh.2019.01.026 (2019).","journal-title":"Clin. Gastroenterol. hepatol."},{"key":"5196_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325. https:\/\/doi.org\/10.1002\/hep.21178 (2006).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05196-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05196-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05196-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:31:19Z","timestamp":1669325479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05196-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5196"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05196-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"15 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1717"}}